Clinical Trial Update: A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 long-term study of TS-172 for hyperphosphatemia in patients on hemodialysis is currently recruiting. The trial aims to evaluate safety and efficacy ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• TS-172

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Hyperphosphatemia Patients on Hemodialysis | Phase 3 | Status: RECRUITING